Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02464111 · ClinicalTrials.gov registry record · NA
Short Term Response of Breast Milk Micronutrient Concentrations to a Lipid Based Nutrient Supplement in Guatemalan Women
A NA study, sponsored by USDA, Western Human Nutrition Research Center.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT02464111: Completed NA study, sponsored by USDA, Western Human Nutrition Research Center.
NCT02464111 is a NA study that has completed, run by USDA, Western Human Nutrition Research Center. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02464111, a NA study, has completed, sponsored by USDA, Western Human Nutrition Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
Research goals include evaluating the relative impact of maternal nutritional status versus recent dietary intake on breast milk micronutrient composition, and evaluating the impact of a maternal lipid based nutrient supplement (LNS) on breast milk micronutrient composition.
Primary Outcome
We are observing the change in breast milk vitamin B12 over the course of 8 hours.
Interventions
- OTHER Treatment 1: Control
- DIETARY_SUPPLEMENT Treatment 2: Bolus (LNS)
- DIETARY_SUPPLEMENT Treatment 3: Divided Dose (LNS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2015-05 |
| Est. Completion | 2015-08 |
| Phase | NA |
What the finished NCT02464111 record still lists
NCT02464111 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which Treatment 1: Control is the first listed.
NCT02464111 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02464111 about?
NCT02464111 is a clinical study titled "Short Term Response of Breast Milk Micronutrient Concentrations to a Lipid Based Nutrient Supplement in Guatemalan Women". Research goals include evaluating the relative impact of maternal nutritional status versus recent dietary intake on breast milk micronutrient composition, and evaluating the impact of a maternal lipid based nutrient supplement (LNS) on breast milk micronutrient composition.
What is the current status of trial NCT02464111?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2015-05. Estimated completion is 2015-08.
What interventions are being tested in trial NCT02464111?
The interventions under investigation include: Treatment 1: Control (OTHER), Treatment 2: Bolus (LNS) (DIETARY_SUPPLEMENT), Treatment 3: Divided Dose (LNS) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02464111?
This trial is sponsored by USDA, Western Human Nutrition Research Center, which has 47 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02464111's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia